Overview This article describes a TruSeq (Illumina, Inc. San Diego, CA) RNA library preparation method for FFPE samples that uses the Biomek automation platform (Beckman […]
Abstract The rise in the development of biosimilar therapeutics has caused increasing demand for new approaches for precise, sensitive and accurate bioanalysis. In this white […]
A truly made-in-Canada treatment for one of the world’s most devastating diseases could be closer to patients thanks to a new technology targeting Alzheimer’s disease […]
A new potential target for battling disease-causing bacteria – especially deadly bugs that resist current antibiotics – may result from a study by University of […]
Researchers have identified an elusive substrate protein in the most common form of heritable rickets. Diagnosed in toddlers, X-linked hypophosphatemia (XLH) is the most common […]
In a ceremony hosted by the Governor General David Johnston in Ottawa, researchers across disciplines, universities and levels of study were recognized for their achievements […]
Qu Biologics is launching a phase 1/2 clinical trial to evaluate the potential clinical response and disease remission among participants with Crohn’s disease treated with […]
ViiV Healthcare today announces 24 week data from the Phase III 48 week SAILING study evaluating the investigational integrase inhibitor dolutegravir for patients who are […]
Alexion Pharma Canada announces that Health Canada has approved the use of Soliris® (eculizumab) for the treatment of patients with atypical hemolytic uremic syndrome (atypical […]
Copyright © 2016 | WordPress Theme by MH Themes
